Sign in

CIK 0001820190

  • Emerging growth company

Scilex Holding Co

Sign in to watch
Ticker
SCLX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-516-4310
Business address
960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
Former names
Scilex Holding Company/DE, Vickers Vantage Corp. I

Securities

  • SCLX Common Stock Nasdaq
  • SCLXW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-17 Ji Henry Exec Chair, CEO and President Sale · Warrant (right to buy) −650,000 $0.15 $100K 2,600,000
2026-04-16 Ji Henry Exec Chair, CEO and President Purchase · Warrant (right to buy) +3,250,000 $0.15 $500K 3,250,000
2025-10-08 Ji Henry CEO and President Grant or award · Incentive Stock Option (right to buy) +120,000 120,000
2024-10-31 Ji Henry Executive Chairperson Purchase +8,888 $0.94 $8K 320,161
2024-10-17 Ji Henry Executive Chairperson Purchase +10,000 $0.97 $10K 60,070
2024-06-18 Ji Henry Executive Chairperson Option exercise +6,000 $1.41 $8K 311,273
2024-06-18 Ji Henry Executive Chairperson Option exercise · Nonstatutory Stock Option (right to buy) −6,000 194,000
2024-05-17 Ji Henry Executive Chairperson Purchase +50,000 $0.88 $44K 50,070
2023-10-04 Ji Henry Executive Chairperson Grant or award · Nonstatutory Stock Option (right to buy) +200,000 200,000
2023-03-17 Ji Henry Executive Chairperson Other acquisition +2,730 $8.60 $23K 2,730
2023-01-17 Ji Henry Executive Chairperson Grant or award · Nonstatutory Stock Option (right to buy) +9,000,000 9,000,000

Page 1 of 1 · 11 trades